Search results for "Conti"

showing 10 items of 3486 documents

Fixed or adjustable sling in the treatment of male stress urinary incontinence: results from a large cohort study

2020

BACKGROUND: Fixed and adjustable male slings for the treatment of male urinary stress incontinence became increasingly popular during the last decade. Although fixed slings are recommended for the treatment of mild to moderate stress urinary incontinence, there is still a lack of evidence regarding the precise indication for an adjustable male sling. Furthermore, there is still no evidence that one type of male sling is superior to another. However, both, adjustable and fixed slings, are commonly utilized in daily clinical practice. This current investigation aims to evaluate the differences between fixed and adjustable male slings regarding indications, complication rates and functional ou…

medicine.medical_specialtyUrethral stricturebusiness.industryUrologyMedical recordUrinary incontinencemedicine.diseaseLarge cohortSling (weapon)Surgeryddc:03 medical and health sciences0302 clinical medicineReproductive MedicineQuality of life030220 oncology & carcinogenesisCohortmedicineOriginal Articlemedicine.symptomComplicationbusiness030217 neurology & neurosurgery
researchProduct

The mainz-pouch (mixed augmentation ileum 'n zecum) for bladder augmentation and continent diversion

1985

The ideal urinary reservoir constructed from bowel material should be a low-pressure system with a high capacity, capable of preventing upper tract deterioration resulting from ureteral obstruction or reflux. It should achieve reliable control of continence and assure easy emptying of the reservoir. In the Mainz-pouch, the combination of cecum and ileum, the latter of which is able to absorb pressure waves created by the cecum, produces a low-pressure system with a high capacity immediately postoperatively. By incorporating large bowel in our pouch, ureteral implantation can be done using a simple and reliable standard antireflux technique with a submucosal tunnel. The Mainz-pouch has been …

medicine.medical_specialtyUrinary bladderbusiness.industryUrologyUrinary systemmedicine.medical_treatmentUrinary diversionInvaginationSurgeryCystectomymedicine.anatomical_structureBladder augmentationmedicinePouchbusinessContinent Urinary DiversionWorld Journal of Urology
researchProduct

2021

Objective: Radical prostatectomy (RP) is a frequent treatment for men suffering from localized prostate cancer (PCa). Whilst offering a high chance for cure, it does not come without a significant impact on health-related quality of life. Herein we review the common adverse effects RP may have over the course of time.Methods: A collaborative narrative review was performed with the identification of the principal studies on the topic. The search was executed by a relevant term search on PubMed from 2010 to February 2021.Results: Rates of major complications in patients undergoing RP are generally low. The main adverse effects are erectile dysfunction varying from 11 to 87% and urinary incont…

medicine.medical_specialtyUrinary continencebusiness.industryProstatectomymedicine.medical_treatment030232 urology & nephrologyUrinary incontinencemedicine.disease03 medical and health sciencesProstate cancer0302 clinical medicineErectile dysfunctionQuality of life030220 oncology & carcinogenesismedicineSurgeryMajor complicationmedicine.symptomAdverse effectbusinessIntensive care medicineFrontiers in Surgery
researchProduct

Treatment of Patients with Bladder Exstrophy or Incontinent Epispadias

1997

Objective: To determine the late outcome concerning urinary continence, late complications, sexuality, and fertility in patients with the exstrophy-epispadias complex. Methods: Until July 1994, 115 patients underwent surgical treatment at our institution. The mean follow-up period in 102 patients is 16.7 years. Urinary diversion was performed in 88 patients, a modified Young-Dees procedure in 8, a sling plasty in 3, and genital reconstruction alone in 3 patients. Results: The present continence rates are 96% for rectal reservoirs, 97% for Mainz pouch I, and 67% for the modified Young-Dees procedure. The upper tracts have remained stable, and no bowel neoplasms have developed. 16 of 17 women…

medicine.medical_specialtyUrinary continencebusiness.industryUrologymedicine.medical_treatmentUrinary diversionUterine prolapseUrinary incontinenceEpispadiasmedicine.diseaseIntroitusSurgeryBladder exstrophymedicineEpididymitismedicine.symptombusinessEuropean Urology
researchProduct

Ultrasound imaging of the pelvic floor: Where are we going?

2011

We produced a non systematic review of ultrasound imaging of the pelvic floor in women with urinary incontinence (UI) and/or pelvic organ prolapse (POP). We have searched the PubMed and Embase databases for the following PICO question: women; imaging; urinary incontinence, pelvic organ prolapse, pelvic floor, pelvic floor muscle, pelvic floor muscle training; physical examination, no imaging; diagnosis, prognosis, outcome. The production of a systematic review was deemed impossible based on the type and quality of the published evidence. Clinical research focused on the pathophysiology of the UI and POP looking relation between anatomic abnormalities, childbirth, the risk of UI or POP, the …

medicine.medical_specialtyUrologyMEDLINEUrinary incontinencePhysical examinationPelvic Floor MusclePredictive Value of TestsRisk Factorspelvic floorHumansMedicineChildbirthpelvic organ prolapse; pelvic floor; ultrasonography; urinary incontinence; imagingPhysical Therapy ModalitiesSuburethral SlingsEvidence-Based Medicineurinary incontinencePelvic floormedicine.diagnostic_testbusiness.industryGeneral surgeryReproducibility of ResultsimagingultrasonographyEvidence-based medicinepelvic organ prolapseSurgerybody regionsTreatment OutcomeLevator animedicine.anatomical_structureUrologic Surgical ProceduresFemaleNeurology (clinical)medicine.symptombusinessNeurourology and Urodynamics
researchProduct

Do overactive bladder symptoms and their treatment-associated changes exhibit a normal distribution? Implications for analysis and reporting

2020

Aims: To explore the use of means vs medians (assuming or not the presence of normal distribution) in studies reporting overactive bladder syndrome symptoms and to test for normal distribution of basal values and treatment-associated changes thereof in two large noninterventional studies. Methods: Systematic review of all original studies reporting on at least one overactive bladder syndrome symptom published in four leading urology journals in 2016 to 2017. Testing of the normal distribution of urgency, incontinence, frequency, and nocturia in two large noninterventional studies (n = 1335 and 745). Results: Among 48 eligible articles, 86% reported means (assuming a normal distribution), 6%…

medicine.medical_specialtyUrologyMedizin030232 urology & nephrologyNormal Distribution610 MedizinNormal distribution03 medical and health sciencesBasal (phylogenetics)0302 clinical medicineInternal medicine610 Medical sciencesmedicineNocturiaHumansBaseline values030219 obstetrics & reproductive medicinebusiness.industryUrinary Bladder Overactivemedicine.diseaseOveractive bladder syndrome3. Good healthUrinary IncontinenceOveractive bladderPropiverineNocturiaNeurology (clinical)medicine.symptombusinessmedicine.drug
researchProduct

Continent diversion with the Mainz pouch.

1996

From 1983 until July 1994, 561 patients in 2 urology departments (Mainz and Wuppertal) underwent a Mainz pouch 1 procedure. The Mainz pouch 1 was used for bladder augmentation in 60 patients, for orthotopic bladder substitution in 61 patients, and for continent cutaneous urinary diversion in 440 patients. In the group of continent cutaneous urinary diversion, the continence mechanism applied was an ileal intussusception nipple in 270 patients, an appendix stoma in 146 patients, a submucosal seromuscular bowel-flap tube in 14 patients, and a submucosal full-thickness bowel-flap tube in 10 patients. Indications for urinary diversion were bladder cancer in 339 patients, anatomical or functiona…

medicine.medical_specialtyUrologyUrinary systemmedicine.medical_treatmentUrinary LeakagePostoperative ComplicationsIleumRisk FactorsmedicineHumansCecumBladder cancerbusiness.industryUrinary retentionUrinary diversionUrinary Reservoirs Continentmedicine.diseasePrognosisAppendixSurgerySurvival Ratemedicine.anatomical_structureBladder augmentationEvaluation Studies as TopicPouchmedicine.symptombusinessFollow-Up StudiesWorld journal of urology
researchProduct

Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis

1994

Between 1988 and 1990 an unblinded, randomized trial of terlipressin or vasopressin plus transdermal nitroglycerin, as part of a treatment strategy including emergency sclerotherapy for actively bleeding varices, was conducted during 165 admissions in 137 patients with cirrhosis and upper digestive bleeding. Eighty-four patient admissions were assigned to terlipressin (2 mg every 6 h) and 81 to vasopressin (0.4 to 0.8 unit per min) plus transdermal nitroglycerin (20 to 80 mg). The two groups were comparable for relevant clinical data, but there were slightly more patients with hepatocellular carcinoma or terminal conditions in the terlipressin group. After the 24-h study period, failure to …

medicine.medical_specialtyVasopressinCirrhosisHepatologybusiness.industrymedicine.medical_treatmentmedicine.diseaseSurgerylaw.inventionDiscontinuationRandomized controlled triallawAnesthesiamedicineSclerotherapyUpper gastrointestinal bleedingbusinessTerlipressinVaricesmedicine.drugJournal of Hepatology
researchProduct

Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The Pethema Registry Experience

2020

Introduction The prognosis of patients with recurrent or refractory acute myeloid leukemia (AML-RR) is very poor, especially if they are not candidates for allogeneic transplantation (allo-SCT) after a second complete response (CR). Venetoclax, a potent and selective inhibitor of the antiapoptotic protein BCL-2, was approved by the FDA in combination with hypomethylating agents (HMAs) or low-dose cytarabine (LDAC) in patients with newly diagnosed AML of age ≥ 75 years, or who have comorbidities that preclude the use of intensive chemotherapy. However, the evidence in AML-RR patients is still scarce. For this reason, the objective of our study is to retrospectively analyze the efficacy of th…

medicine.medical_specialtyVenetoclaxbusiness.industryImmunologyDecitabineCell BiologyHematologymedicine.diseaseBiochemistryDiscontinuationRegimenchemistry.chemical_compoundLeukemiachemistryRefractoryInternal medicineCohortmedicineCytarabinebusinessmedicine.drugBlood
researchProduct

Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or comb…

2021

Purpose Ranibizumab monotherapy showed stronger effects on area of retinal neovascularization (NV) reduction while offering better visual acuity (VA) results than panretinal laser photocoagulation (PRP) monotherapy during the first 12 months of the PRIDE study. The second year of PRIDE was an observational, non-interventional follow-up, performed to evaluate long-term anatomical and functional outcomes in proliferative diabetic retinopathy (PDR) patients under real-life conditions, prior to the approval of ranibizumab for PDR. Methods Seventy-three PDR patients (28 from the ranibizumab group; 20 from the PRP group; 25 from the combination group) were included in the observational follow-up …

medicine.medical_specialtyVisual acuityCombination therapyVisual AcuityAngiogenesis InhibitorsLight CoagulationPanretinal laser photocoagulation03 medical and health sciencesRetinal neovascularization0302 clinical medicineOphthalmologyRanibizumabMedicineHumansDiabetic Retinopathybusiness.industryGeneral MedicineDiabetic retinopathymedicine.diseaseCombined Modality TherapyDiscontinuationOphthalmologyIntravitreal Injections030221 ophthalmology & optometryObservational studyRanibizumabmedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugFollow-Up StudiesActa ophthalmologicaReferences
researchProduct